Pharmaceutical compound having inhibitory activity against cholesterol acyltransferase isozyme 2 (ACAT2)
US9896456B2 · kind B2 · utility
1Cited by
1References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 18, 2015 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Jun 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides a novel non-natural pharmaceutical compound having a different mechanism than statin drugs and having a selective inhibitory activity against ACAT2. This invention relates to the compound represented by Formula (I), a salt thereof, or a solvate thereof:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.